Stay updated with breaking news from Microbiome Ecosystem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulatory News: MaaT Pharma (EURONEXT: MAAT the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing
Regulatory News: THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR...
Regulatory News: MaaT Pharma , a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM dedicated to enhancing survival for patients with cancer,...
Regulatory News: MaaT Pharma , a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM dedicated to enhancing survival for patients with cancer,...
LYON, France, April 05, 2024--Regulatory News: MaaT Pharma (EURONEXT: MAAT – the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival of patients with cancer, announces the initiation of coverage of its stock by Gilbert Dupont.